发明名称 New 4-amino-quinazoline or quinoline derivatives, are tyrosine kinase-mediated signal transduction inhibitors useful e.g. for treating tumors, polyps or respiratory or gastrointestinal diseases
摘要 6,7-Disubstituted 4-amino-quinazoline or quinoline derivatives (I) are new. Bicyclic heterocycles of formula (I) and their tautomers, stereoisomers and salts are new. Ra = H or T; T = 1-4C alkyl; Rb = Ph', CH2Ph' or CHMePh'; Ph' = substituted phenyl; Rc, Rd = H, F, Cl or OMe; or Me optionally substituted (os) by OMe, NMe2, NEt2, pyrrolidino, piperidino or morpholino; X = C-CN or N; A = O, NH or NT; B' = CO or SO2; C' = CH=C=CH, C=CH2 or CH=CH (all os by 1 or 2 Me or by CF3); C?=C; or CH=CHCH=CH (os by 1-4 Me or by CF3); D = Q1, COQ1, SO2Q1, COOQ2, CONR4Q2 or SO2NR4Q2 (all bonded to E via Q1 or Q2); or may also be a bond if bonded to C in E or CO or SO2 if bonded to N in E; Q1 = 1-8C alkylene (os by 1-4 F); Q2 = 1-8C alkylene; R4 = H or T; E = NR5Q3COOR6, NR5Q3P(O)(OR7)OR8 or NR5Q3P(O)(OR7)R9; Q3 = optionally substituted 1-6C n-alkylene; R5 = H, optionally substituted T; os Et or propyl, which may be terminally substituted; R6-R8 = H; os 1-8C alkyl or 4-7C cycloalkyl; alkenyl or alkynyl (both not alpha -unsaturated); or -T-cycloalkyl, Ar, -T-Ar or CReRfOCORg; Re, Rf = H or T; Rg = T, cycloalkyl, OT or 5-7C cycloalkoxy; R9 = T, Ar or -T-Ar; substituted imino; or G1; or -D-E = H, F, Cl, T (os by 1-5 F), 3-6C cycloalkyl, Ar, Het, COT, COAr, COOH, COOT, COOCReRfCOOR9, P(O)(OR7)OR8, P(O)(OR7)R9, CONH2, CONHT, CON(T)2 or COQ'4; F' = 1-6C alkylene, 1-6C oxyalkylene (linked to G via C) or O (not linked to N in G); G = G1; or as defined for E; or -F'-G = H, F, Cl, 1-6C alkoxy (os), cycloalkoxy, cycloalkylalkoxy, NH2, NHT, N(T)2 or Q'4 (other than 4-membered alkyleneimino); G1 = substituted 4-7 membered alkyleneimino, morpholino or homomorpholino, piperazino or homopiperazino, pyrrolidinyl, piperidinyl or hexahydroazepinyl; os 2-oxo-morpholinyl (linked to C in F'); morpholino or thiomorpholino 2-substituted or 2,6-disubstituted by OT etc.; Q'4 = 4-7 membered alkyleneimino (where CH2 in the 4-position may be replaced); Ar = os phenyl; Het = 5-membered heteroaryl (containing NH, O or S and optionally 1 or 2 N) os by 1 or 2 Me or Et or 6-membered heteroaryl (containing 1-3 N) os by 1 or 2 Me or Et or by halo, CF3, OH, OMe or OEt; with provisos; unless specified otherwise alkyl moieties have 1-3C, alkenyl or alkynyl moieties 3-5C and cycloalkyl moieties 3-7C. Full Definitions are given in the DEFINITIONS (Full Definitions) field. An Independent claim is included for the preparation of (I).
申请公布号 DE19954816(A1) 申请公布日期 2001.05.17
申请号 DE1999154816 申请日期 1999.11.13
申请人 BOEHRINGER INGELHEIM PHARMA KG 发明人 HIMMELSBACH, FRANK;LANGKOPF, ELKE;JUNG, BIRGIT;FLAVIO, SOLCA
分类号 A61K31/47;A61K31/505;C07D215/42;C07D239/94;(IPC1-7):C07D239/94 主分类号 A61K31/47
代理机构 代理人
主权项
地址